South Glamorgan, United Kingdom

Michael John Owen



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 1999-2001

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Michael John Owen: Pioneering Research in Alzheimer's Disease

Introduction

Michael John Owen is an esteemed inventor based in South Glamorgan, Great Britain. With a focus on groundbreaking developments in the field of Alzheimer's disease, Owen holds two patents that contribute significantly to understanding and modeling this complex condition.

Latest Patents

Owen's recent patent, titled "Transgenic mouse expressing an APP-FAD DNA sequence," presents vital insights into model systems of Alzheimer's disease. This invention comprises a DNA sequence encoding an amyloid precursor protein (APP) isoform or fragment that includes an amino acid substitution. The substituted amino acid is distinct from valine at the corresponding amino acid residue position 717 of APP770. Additionally, the patent showcases methods for determining genetic predisposition to Alzheimer's disease, showcasing Owen's commitment to advancing medical research.

His second patent, "APP770 mutant in Alzheimer’s disease," further explores the implications of APP mutations on Alzheimer’s pathology, offering new avenues for research and potential therapeutic interventions.

Career Highlights

Throughout his career, Michael John Owen has made significant contributions to the scientific community, particularly in the realm of neurodegenerative disorders. He has worked at prestigious institutions, including the Imperial College of Science, Technology and Medicine, as well as Elan Pharmaceuticals, Inc. His roles in these organizations have allowed him to translate complex genetic research into impactful inventions.

Collaborations

Owen has collaborated with notable figures in the field, including John Anthony Hardy and Marie-Christine Chartier-Harlin. These partnerships have facilitated a deeper understanding of Alzheimer's disease, combining diverse expertise and perspectives to tackle this pressing health issue.

Conclusion

Michael John Owen stands out as a vital contributor to innovations in Alzheimer's research. His patents not only enhance the scientific understanding of this debilitating disease but also pave the way for future advancements in treatment and prevention strategies. Through his work, Owen continues to inspire the next generation of inventors and researchers committed to combating Alzheimer's disease and improving patients' lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…